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Eukaryotic initiation factor 2A (eIF2A) has been
shown to direct binding of the initiator methionyl-tRNA
(Met-tRNAi) to 40 S ribosomal subunits in a codon-de-
pendent manner, in contrast to eIF2, which requires
GTP but not the AUG codon to bind initiator tRNA to 40
S subunits. We show here that yeast eIF2A genetically
interacts with initiation factor eIF4E, suggesting that
both proteins function in the same pathway. The double
eIF2A/eIF4E-ts mutant strain displays a severe slow
growth phenotype, which correlated with the accumu-
lation of 85% of the double mutant cells arrested at the
G2/M border. These cells also exhibited a disorganized
actin cytoskeleton and elevated actin levels, suggesting
that eIF2A might be involved in controlling the expres-
sion of genes involved in morphogenic processes. Fur-
ther insights into eIF2A function were gained from the
studies of eIF2A distribution in ribosomal fractions ob-
tained from either an eIF5B (fun12) strain or a
eIF3b-ts (prt1-1) strain. It was found that the binding of
eIF2A to 40 and 80 S ribosomes was not impaired in
either strain. We also found that eIF2A functions as a
suppressor of Ure2p internal ribosome entry site-medi-
ated translation in yeast cells. The regulation of expres-
sion from theURE2 internal ribosome entry site appears
to be through the levels of eIF2A protein, which has
been found to be inherently unstable with a half-life of
17 min. It was hypothesized that this instability allows
for translational control through the level of eIF2A pro-
tein in yeast cells.
Initiation of protein synthesis in eukaryotes is a complex
process requiring numerous accessory proteins called initiation
factors. At least 12 different initiation factors have been iden-
tified, comprising over 30 polypeptide chains (1). The function
of many of these factors have been established in detail (1, 2);
however, the precise role of some of them, their mechanism of
action, and the particular step in the initiation process at which
these factors function still remains obscure. It should be noted
that recent studies have pointed to the key role of translational
control (which is mainly exerted at the initiation step of protein
synthesis) in regulating gene expression during development,
differentiation, cell cycle progression, cell growth, apoptosis,
and stress (3–5). Studies of the responses of a large variety of
cell systems to different physiological stimuli have shown that
protein synthesis can be modulated by both changes in the
state of phosphorylation of initiation factors and changes in the
levels of these factors in the cell. These effects allow rapid
modification of the overall rate of translation as well as post-
transcriptional regulation of gene expression due to changes in
the relative selection of different mRNA species utilizing dif-
ferent mechanisms of translation initiation. In view of these
observations, it is of importance to establish the molecular
mechanisms by which changes in the levels or activities of
various initiation factors could affect cell fate.
Eukaryotic initiation factor 2A (eIF2A)1 is a 65-kDa protein
that was first identified in the early 1970s on the basis of its
stimulation of initiator methionyl-tRNA (Met-tRNAi) binding
to 40 S ribosomal subunits, its participation in methionyl pu-
romycin synthesis, and its ability to stimulate poly(U)-directed
polyphenylalanine synthesis at low [Mg2]. eIF2A was initially
believed to be the functional homologue of prokaryotic IF2,
since IF2 catalyzes biochemically similar reactions (6, 7). Sub-
sequent identification of a multisubunit factor eIF2 (8–10)
showed that this factor and not eIF2A is primarily responsible
for the delivery of Met-tRNAi to 40 S subunits in eukaryotes.
Whereas both eIF2 and eIF2A function similarly in model
assays, the order of events differs between the two (Fig. 1).
eIF2A binds Met-tRNAi to 40 S subunits in a codon-dependent
manner, whereas eIF2 binds Met-tRNAi to 40 S subunits in a
GTP-dependent manner (7, 11–13). Recently, the yeast homo-
logue of mammalian eIF2A was identified, and yeast strains
were obtained that lacked the gene for eIF2A (14). The eIF2A
strains were viable and showed no apparent phenotype (al-
though this strain sporulated with about one-third the effi-
ciency of the wild type (14)), suggesting that the eIF2A does not
function in major (key) steps in the initiation process but,
perhaps, could act at some late steps or be involved in minor
alternative initiation events such as reinitiation, internal ini-
tiation, or non-AUG initiation. Of these alternatives, it does not
appear that eIF2A influences reinitiation, at least as tested
using the GCN4 reporter system in yeast cells (14). Genetic
interaction of the eIF2A and eIF5B was also observed, suggest-
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ing that both proteins function in the same pathway (14).
In this paper, we have further characterized the yeast eIF2A
using both genetic and biochemical approaches. We show here
that eIF2A genetically interacts with eIF4E, suggesting that
both proteins function in the same pathway. The double
eIF2A/eIF4E-ts mutant strain displayed a severe slow growth
phenotype. This synthetic slow growth correlated with the ac-
cumulation of the double mutant cells arrested at the G2/M
border. Furthermore, disruption of the eIF2A gene in the
eIF4E-ts strain 4-2 caused a strong disorganization of the actin
cytoskeleton and accumulation of actin protein at elevated
levels. We also show that eIF2A acts as a suppressor of the
internal ribosome entry site (IRES) element found in theURE2
mRNA. Analysis of eIF2A distribution in ribosomal fractions of
various yeast mutants suggests that this inhibition occurs at
the level of 40 S/80 S ribosomes. We also found that eIF2A is an
inherently unstable protein with a half-life of 17 min. We
hypothesize that this instability allows for translational control
through the level of eIF2A protein in yeast cells.
MATERIALS AND METHODS
Yeast Strains and Growth Methods—Yeast strains used in this study
are listed in Table I. Wild-type BY4741 (Mata, his3-1, leu2-0, met15-0,
ura3-0) and isogenic eIF2A (Mata, his3-1, leu2-0, met15-0, ura3-0,
ygr054w::KanMX) strains have been described previously (14) and were
used in lacZ expression experiments. The disruption of the eIF2A gene
in the eIF2A strain (open reading frame YGR054W) was verified by
PCR (with 5-GTACTACAACAAACAGTCAGGTTCAATAACACC-3 as
the upstream and 5-CACAGTTGTATGGATACATCAGTTTCTTCTAG-3
as the downstream primer). Strains H2879 (MATa, leu2-3, leu2-112,
ura3-52, PRT1), H1676 (MATa, leu2-3, leu2-112, ura3-52, prt1-1),GIM3
(Mata, his3-1, leu2-0, met15-0, ura3-0, gim3::KanMX), GIM5 (Mata,
his3-1, leu2-0, met15-0, ura3-0, gim5::KanMX) and PAC10 (Mata,
his3-1, leu2-0, met15-0, ura3-0, pac10::KanMX) were kindly provided by
Dr. Thomas Dever (National Institutes of Health). eIF5B (Mata, his3-1,
leu2-0, met15-0, ura3-0, fun12::KanMX) strain has been obtained from
Research Genetics. The eIF4E-ts strain 4-2 (MATa, ade2-1, leu2-3,112,
his3-11,15, trp1-1, ura3, cdc33::LEU2cdc33-4-2; TRP1, ARSCEN) has
also been previously described (15, 16). The eIF4E-ts strain 4–2/2A
(MATa, ade2-1, leu2-3,112, his3-11,15, trp1-1, ura3, ygr054w::KanMX,
cdc33::LEU2 cdc33-4-2; TRP1, ARSCEN) was obtained as follows.
Genomic DNA from eIF2A (Mata, his3-1, leu2-0, met15-0, ura3-0,
ygr054w::KanMX) strain was amplified by PCR using 5-CTTAGTGTT-
GATTGAGACGTGTTGTG-3 as an upstream and 5-GGCGTAATTCTC-
CTGGGAAACAG-3 as a downstream primer, and the PCR fragment was
further used for transformation of the eIF4E-ts strain 4-2. Transformants,
which were able to grow on medium containing G418 sulfate and showed
a ts-phenotype, were further checked for homologous gene recombination
by PCR.
Yeast cultures were grown as indicated using either synthetic me-
dium containing 0.67% Difco yeast nitrogen base, 1% ammonium sul-
fate, 2% glucose (or galactose) and supplemented with the appropriate
amino acids or complete (YEPD) medium (17). Transformation was
performed using the lithium acetate method (18). For the polysome
expression analysis of HA-tagged eIF2A, yeast were grown in complete
medium with 2% galactose.
Plasmids—The pTB328_y_2A shuttle vector bearing yeast eIF2A
(fused to an HA epitope) under control of the GAL promoter has been
previously described (14). The YCplac111 (CEN, LEU2) vector bearing
yeast eIF2A under its own promoter was produced by BamHI-PstI
subcloning of the PCR-amplified (3339 bp) yeast genomic DNA frag-
ment (with 5-AACGCGGATCCCTATTATCTATGAATATAAACTGTC-
TATCTTTCC-3 as the upstream and 5-AAAACTGCAGCCATGGTGT-
GCAATAACTGCGAAGGTAGCACCGC-3 as the downstream primer)
into the YCplac111 vector. This fragment contains 843 bp upstream of
the eIF2A AUG start codon. The pRS316_y_2A (CEN, URA3) plasmid
was constructed as follows. Yeast eIF2A genomic DNA fragment (3809
bp) was PCR-amplified with 5-TTGGTTCAAATTATTGGCTGTAGG-3
as an upstream primer and 5-TTGTATGGATGGATCCGTTTCTTCT-
AGTTTATTC-3 as downstream digested with KpnI and XhoI and
cloned into KpnI-SalI-digested pRS316 vector. The pTB328_h_2A vec-
tor bearing the cDNA copy of human eIF2A under control of GAL
promoter was produced as follows. cDNA encoding human eIF2A
(I.M.A.G.E. Consortium Clone ID 3688407) was amplified by PCR (with
5-AAACGCGGATCCATGGCGCCGTCCACGCC-3 as the upstream
and 5-AAAACTGCAGGTCTTTATTCATTTACATGGTATATATCAC-
C-3 as the downstream primer), digested with BamHI and PstI, and
cloned into pTB328 (CEN, LEU2, GAL1 promoter, HA tag) vector. The
p281 plasmid containing lacZ under GAL promoter has been described
previously (19). The pDAD2-eIF4E(HA tag) vector containing HA-
tagged yeast eIF4E under the control of GAL promoter (URA3 as an
auxotrophic marker) was kindly provided by Dr. Nahum Sonenberg
(McGill University). The p281-4-URE2 and p281-4-URE2_CTT vectors
have also been previously described (20).
Northern Blot Analysis—Northern blotting was performed generally
as described (21) with slight modifications following the general proce-
dures described previously (20). For detection of Ure2_lacZ mRNAs, the
PCR-amplified 3-kb lacZ fragment (with 5-CGCCTTGCAGCA-
CATCC-3 as the upstream and 5-GGTAGCGACCGGCGC-3 as the
downstream primer) was random prime-labeled using the Ambion Ran-
dom Primed Strip Able DNA probe synthesis and removal kit. RNA
electrophoresis was accomplished using the Glyoxal-based system (Am-
bion). Ambion RNAMillenniumMarkersTM were used as molecular size
standards. Yeast total RNA was prepared using the RNAqueous™ kit
from Ambion. The 5-end 32P-labeled anti-HA primers (5-GCCCGCAT-
AGTCAGGAACATCGTATGGGTA-3 for HA-eIF2A and 5-AGAAGCG-
TAGTCTGGCACGTCGTATGGGTA-3 for HA-eIF4E) were used to
probe for eIF2A and eIF4E mRNAs expressed from the GAL promoter.
Note that the nucleotide (but not the amino acid) sequence of HA tag
attached to eIF2A and eIF4E open reading frames differs slightly, and
this is why two different primers were used.
Fractionation of Ribosomes—Fractionation of ribosomes was per-
formed essentially as described before (14). All procedures were per-
formed at 4 °C except where indicated. Yeast cells from 50 ml of log
phase culture were pelleted, treated for 1 min with 10 g/ml cyclohex-
imide (Calbiochem), and repelleted. Lysates were made by glass bead
cell disruption (3–5 cycles, 1 min each), with intermittent cooling on ice,
in buffer that contained 100 mM KCl, 2 mM magnesium acetate, 20 mM
HEPESKOH, pH 7.4, 14.4 mM -mercaptoethanol, 100 g/ml cyclohex-
imide. Cell debris was removed by centrifugation at 7000 rpm for 8 min.
Ribosomes were resolved in 10–25% sucrose gradients containing 100
mM KCl, 5 mM MgCl2, 20 mM HEPESKOH, pH 7.4, and 2 mM dithio-
threitol (Beckman SW28 rotor, 20,000 rpm, 19.5 h). Gradients were
collected with continuous monitoring at 254 nm using an ISCO UA-5
absorbance detector and 1640 gradient collector. Proteins collected from
sucrose gradient fractions were precipitated with 10% trichloroacetic
acid and resolved in 10% Laemmli SDS-polyacrylamide gel electro-
phoresis and transferred onto Immobilon (Millipore Corp.) membranes.
Western Blotting—Western blotting was performed following stan-
dard procedures (22). For studying eIF2A time course degradation
experiments, yeast extracts were obtained by glass beads disruption of
the yeast cells mixed with protein loading buffer. After vigorous vortexing,
the beads and cell debris were removed by centrifugation at 14,000 rpm
for 5 min, and Western blots were decorated with either mouse mono-
clonal anti-HA tag antibodies (Cell Signaling, Inc.) or with custom made
rabbit anti-eIF2A antibodies followed by incubation with either goat anti-
mouse or goat anti-rabbit horseradish peroxidase-conjugated antibodies.
The antibodies for actin and phosphoglycerate kinase were obtained from
FIG. 1. Two pathways for the formation of model 80 S initia-
tion complexes (adapted from Ref. 1 with the use of current
nomenclature).
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Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). The blots were then
detected with an ECLTM kit (Amersham Biosciences).
Expression and Purification of a Recombinant eIF2A Protein Frag-
ment—eIF2A cDNA fragment (comprising residues Gly59–Glu420) was
amplified by PCR using 5-AACGCGGATCCGGTCCATGTTTGGATA-
ACGTTCTATTAAC-3 as an upstream primer and 5-TTCCGGAATT-
CCTCTTTAACAAATACTAAAGAGCCTGATACATGC-3 as a downst-
ream primer, digested with BamHI and EcoRI, and cloned into pMW-
127 vector (23, 24) as a fusion to the gene encoding staphylococcal
nuclease bearing on its N-terminal end a His6 tag. The plasmid was
transformed into BL21-CodonPlus (DE3)-RIL (Stratagene) cells. Cells
were grown at 37 °C to an A600 of 0.6, induced with 1 mM isopropyl--
D-thiogalactoside, harvested by centrifugation after 3 h of induction,
and lysed by sonication in 20 mM Tris/HCl, pH 8.0, buffer, containing
complete EDTA-free protease inhibitor mixture tablets (Roche Applied
Science). The recombinant protein was found to be insoluble and was
further purified from the inclusion bodies under denaturing conditions
(6 M urea, 20 mM Tris/HCl, pH 8.0, 0.5 M NaCl, 10 mM imidazole, 1 mM
-mercaptoethanol) on a Ni2-nitrilotriacetic acid beads following sta-
ndard procedures described elsewhere. After the Ni2-nitrilotriacetic
acid column purification, the protein was found to be 95–97% pure and
was then dialyzed against 10 mM Tris/HCl buffer, pH 7.5, containing
0.2% SDS, 1 mM EDTA, and 10 mM -mercaptoethanol and concentr-
ated using an Ultrafree-15 centrifugal filter device (Millipore Corp.) and
further used for immunization of rabbits. Rabbit polyclonal antibodies
were produced by United States Biological, Inc.
Actin Phalloidin Staining—Yeast strains were grown in YEPD me-
dium for 16 h in log phase by continual dilution at 30 °C. Fixation was
performed by adding formaldehyde and Triton X-100 to a final concen-
tration of 4 and 0.5%, respectively, and incubated for 30 min at room
temperature. Yeast pellets were resuspended in PBS buffer plus 0.5 mM
MgCl2 and 4% formaldehyde for further fixation for 90 min at room
temperature. Cells were washed once with PBS prior to phalloidin
addition to a final concentration of 0.6 M in PBS and incubated for 60
min at room temperature in the dark. Yeast samples were subsequently
washed three times with PBS and resuspended in 1 mounting me-
dium (90% glycerol, 0.1% PBS, 92 mM p-phenylenediamine). Images
were captured with an IX70 inverted fluorescence microscope (Olym-
pus) equipped with a HiQ fluorescein filter set (excitation wavelength:
450–492 nm); a Planapochromatic 100 oil immersion objective lens;
and a 100-watt mercury lamp. Images were collected and analyzed with
a Princeton Instruments 5-MHz MicroMax cooled CCD camera, a shut-
ter and controller unit, and IPLab software (version 3.5; Scanalytics).
Flow Cytometry—Yeast strains were grown in YEPD medium for
16 h in log phase by continual dilution at 30 °C. Fixation was performed
by adding ethanol to a final concentration of 70% and incubation over-
night at 4 °C. Yeast pellets were resuspended in 50 mM sodium citrate
(pH 7.0) and digested with RNase I (0.25 mg/ml) for 1.5 h at 50 °C.
Samples were washed three times with 50 mM sodium citrate (pH 7.0)
before suspension in this buffer with 16 g/ml propidium iodide. Sam-
ples were analyzed on a Coulter Cytomics FC500 flow cytometer.
Miscellaneous—Molecular cloning was performed following the gen-
eral procedures described by Sambrook et al. (25). DNA sequencing was
accomplished by the Molecular Biology Core Laboratory at Case West-
ern Reserve University. Sequencing was performed with custom syn-
thesized oligonucleotides using the fluorescently labeled dideoxytermi-
nator methodology. SDS-PAGE was performed according to either the
Laemmli (26) or Schagger and von Jagow (27) procedures. Yeast
genomic DNA was isolated using the DNA-Pure™ Yeast Genomic Kit
from CPG, Inc., following the manufacturer’s protocol. -Galactosidase
activity was measured following the protocol described by Clontech (59)
with o-nitrophenyl -D-galactopyranoside as a substrate. Cell extracts
were prepared by subsequent cycles of cell freezing in liquid nitrogen
and thawing at 37 °C.
RESULTS
The eIF2A null mutant has been shown to have no apparent
phenotype in a variety of systematic tests assaying growth,
metabolism, cell cycle progression, cytoskeleton and mitochon-
drial morphology, mating, stability of an artificial minichromo-
some, rate of spontaneous mutation, etc. (14, 28, 29), although
it was found to possesses reduced sporulation efficiency (14).
We have, however, previously shown that the double 2A/5B
mutant is “synthetically sick.” This suggested a genetic inter-
action between eIF2A and eIF5B (14). To further investigate
the cellular functions of eIF2A in Saccharomyces cerevisiae, we
decided to look for other initiation factors that could possibly
genetically interact with eIF2A. Such genetic relationships, if
they exist, suggest a functional interaction between the corre-
sponding gene products. However, disruption of the vast ma-
jority of the initiation factors in yeast is known to be lethal.
Thus, we decided to take advantage of combining the eIF2A
mutation with some of the yeast temperature-sensitive mu-
tants carrying ts mutations in the respective initiation factors.
As a first step in this line of reasoning, the eIF2A gene (open
reading frame YGR054W) was disrupted in the eIF4E-ts strain
4-2 using the kanMX disruption module and the resulting
eIF4E-ts strain 4-2/2A (MATa, ade2-1, leu2-3,112, his3-11,15,
trp1-1, ura3, ygr054w::KanMX, cdc33::LEU2 cdc33-4-2;
TRP1, ARSCEN) was obtained.
The eIF4E-ts Strain with a Disrupted Copy of the eIF2A Gene
Is Synthetically Sick and Displays an Altered Phenotype—
eIF4E-ts strain 4-2 has two point mutations in the eIF4E gene,
which confer a temperature-sensitive phenotype, resulting in a
rapid shutoff of protein synthesis and cell growth at the non-
permissive temperature (37 °C) (15). However, at permissive
temperatures (2830 °C), this strain displays growth rates
that are only slightly reduced (15).
Surprisingly, the double eIF4E-ts and eIF2A mutant strain
revealed a severe slow growth phenotype (Fig. 2A) when com-
pared with the parental strains. The doubling time for this
strain at 28 °C in liquid YPD glucose medium was found to be
4–4.2 h, whereas for the eIF4E-ts strain, it is about 2.5 h.
This severe slow growth phenotype can be reverted by reintro-
ducing the eIF2A gene on a CEN plasmid (Fig. 2A). Mutations
in the eIF4E (CDC33) gene are known to arrest yeast cells at
random points in the cell cycle (30, 31). To determine whether
the eIF4E-ts/eIF2A null mutant also presents a defect in cell
cycle progression, we analyzed all strains by flow cytometry. At
30 °C, the eIF4E-ts 4-2 strain showed an increased cell popu-
lation in G2 (73% total) (Fig. 2B). This effect was further exag-
gerated to more than 82% in eIF4E-ts/eIF2A null mutant cells
(Fig. 2B), perhaps contributing to the synthetic slow growth
phenotype observed (Fig. 2A).
The 4-2/2A strain also displayed an altered phenotype (cell
morphology) in comparison with ancestor eIF4E-ts strains 4-2
and WT CWO4 (Fig. 2C). On average, the 4-2/2A cells were
larger in size and more rounded in shape, representing almost
perfect circles (Fig. 2C). The establishment of cell morphology
is universal during the development of both uni- and multicel-
lular organisms (32). Wild type yeast cells have a relatively
simple ellipsoidal shape; however, a number of mutants with
elongated, round, small, large, pointed, clumped, and other
shapes have been reported (33). In general, yeast cell growth
and morphogenesis is a complex process, which is tightly linked
to the cell cycle (34). The organization of the actin cytoskeleton
plays a critical role in this morphogenic process (35). It is
therefore possible that in the double eIF4E-ts and eIF2A mu-
tant strain, the expression and/or organization of the actin
cytoskeleton is affected. To check the latter, the actin cytoskel-
eton from the different yeast strains was stained using rhoda-
mine phalloidin, and the samples were analyzed by fluores-
cence microscopy (Fig. 2D). The parental strains CWO4 and
BY4741 revealed similar actin cytoskeleton organization,
where actin cables were generated from the buds and along the
cytoplasm, showing correct polarization toward regions of cell
growth (Fig. 2D and data not shown). Actin cytoskeleton orga-
nization in the eIF4E-ts strain was somewhat altered with a
partial loss of actin cables and depolarization. In contrast to
CW04 and eIF4E-ts strains, cytoskeletal organization, and po-
larization in the eIF4E-ts and eIF2A double mutant strain was
severely affected, with almost complete disruption of the actin
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cytoskeleton resulting in a total loss of the actin cables and
almost complete depolarization (Fig. 2D). It should be noted,
however, that no change in actin cytoskeleton organization was
observed in the single eIF2A mutant strain (data not shown).
To determine whether actin expression was altered at the
protein level, cell extracts were prepared and Western blots for
actin were performed. To our surprise, it was found that actin
levels were not constant in all samples. Strains carrying the
eIF4E-tsmutation presented an increase in actin protein when
compared with its wild type counterpart (30% increase), and
the double eIF4E-ts and eIF2A mutant strain presented even
greater changes with more than a 50% increase in actin levels
(Fig. 2E). Thus, eIF2A might have a critical function in yeast in
controlling (under certain specific conditions) the expression of
the genes involved in cytoskeleton formation and assembly and
this could ultimately lead to a change of cell morphology.
The observed genetic interaction of eIF2A and eIF4E sug-
gests that both proteins function in the same pathway, namely
initiation of protein synthesis. However, we have previously
shown that eIF2A does not affect cap-dependent initiation or
reinitiation in yeast as monitored using various GCN4_lacZ
fusion constructs (kindly provided by Dr. Thomas Dever, Na-
tional Institutes of Health) (14).
It was, however, still possible that eIF2A might affect inter-
nal initiation. To study the effect of eIF2A on IRES-mediated
expression in yeast, the Ure2p-lacZ reporter system was used
(20). In this construct, the URE2 IRES (URE2 open reading
frame amino acids 3–353) was inserted in frame with lacZ and
FIG. 2. Mutant eIF4E-ts yeast strain 4-2/2A with a disrupted copy of the eIF2A gene displays a severe slow growth phenotype. A,
yeast cell growth. Cells were grown for 36 h on a solid YEPD agar medium containing 2% glucose. B, cell cycle distribution. DNA samples collected
from different yeast strains grown for 16 h on liquid YEPD were analyzed by flow cytometry after propidium iodide staining using a Coulter
Cytomics FC500 Flow Cytometer. C, yeast cell morphology. Cells were scraped off of the plate and resuspended in 10 l of water onto microscope
slides. Images were taken using a Zeiss TELAVAL 31 microscope equipped with a Spot Diagnostic Instrument Inc. digital camera at 40
magnification. D, yeast actin cytoskeleton staining with phalloidin. Yeast strains grown in YEPD medium for 16 h in log phase were fixed and
stained with rhodamine phalloidin prior to mounting. Images were captured with an IX70 Olympus inverted fluorescence microscope equipped
with a Planapochromatic 100 oil immersion objective lens. E, levels of the actin protein. Cells were grown in YEPD medium for 16 h (log phase)
and collected, and proteins were extracted. Subsequently, proteins were resolved by SDS-PAGE with the proteins then transferred to cellulose
membranes and probed with antibodies to actin or phosphoglycerate kinase (for loading control). Densitometry analysis was performed using the
Amersham Biosciences software ImageQuant 5.2, and intensity of the signal was corrected against phosphoglycerate kinase blots and expressed
as a percentage of control (BY4741 strain).
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placed behind a stable hairpin structure (30 kcal/mol). This
hairpin structure reduces cap-dependent lacZ expression al-
most completely (20, 36). Two constructs were produced; they
carried at position 94 either ATG-Met (internal initiation start)
or CCT-Leu (ATG was mutated to CCT in order to abolish
internal initiation, used as a negative control) (20). Although
there was almost no expression from the CCT-Leu construct,
there was a significant increase in the level of -galactosidase
expressed in an eIF4E-ts strain at the nonpermissive temper-
ature (37 °C) compared with expression in wild type cells, in-
dicating that the expression from the URE2 IRES is eIF4E-
and cap-independent (Fig. 3) (20).
Expression from the URE2 IRES Is Up-regulated in Yeast
Cells Lacking eIF2A—Surprisingly, it was found that lacZ ex-
pression driven by the URE2 IRES was dramatically enhanced
in the eIF2A null strain in comparison with the WT strain
having the same genetic background and that the observed
increase in the activity was even greater than that measured
for the eIF4E-ts strain at the nonpermissive temperature (Fig.
3A). At the same time as it was noted before (14), cap-depend-
ent initiation in the eIF2A strain was not significantly af-
fected, although a slight increase in its level was observed (Fig.
3A) when using a construct encoding lacZ mRNA with a 5-
untranslated region derived from the GAL1 gene (19). Surpris-
ingly, we also found that the activity of URE2 IRES was not
up-regulated in the double eIF4E-ts and eIF2A mutant strain
at the permissive temperature and was only slightly elevated
at the nonpermissive temperature (Fig. 3A), suggesting that
expression of some other genes required for efficient URE2
IRES utilization may have also been affected in this strain. It
FIG. 3. Activity of the Ure2p IRES is up-regulated in yeast strains carrying eIF4E-ts and/or eIF2A mutations. A, expression of
reporter constructs under the control of the GAL1/10 promoter transformed into eIF4E-ts strain 4-2 or isogenic wild-type BY4741, eIF2A, and
eIF5B strains. Activity in the mutant eIF4E-ts strain 4-2/2A is also shown. -Galactosidase activity (relative units) was determined following the
protocol described by Clontech (59) after a 20-h induction of the cells in 2% galactose at the indicated temperature. B, Northern blot analysis of
Ure2p-lacZ mRNA expressed in eIF4E-ts strain 4-2 or isogenic 4-2/2A strain. For each lane, 25 g of total yeast RNA was separated on a denaturing
agarose gel, transferred onto a BrightStarTM-Plus Nylon membrane (Ambion), and hybridized to a 32P-labeled DNA lacZ probe. rRNA loading
controls are shown to the right of the Northern blots. C, Ure2p IRES activity in isogenic WT BY4741 and GIM3, GIM5, and PAC10 mutant
strains (-galactosidase activity was measured as above).
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should be noted that no reduction of URE2_lacZ mRNA levels
in the double 4-2/2A mutant strain in comparison with the
eIF4E-ts strain 4-2 (at both permissive and nonpermissive tem-
peratures) was observed that could account for the observed
differences in URE2 IRES activity (Fig. 3B). Also, the level of
cap-dependent initiation and the extent of its inhibition at the
nonpermissive temperature in 4-2/2A strain was found to be
very similar to that of eIF4E-ts strain 4-2 (Fig. 3A). In both
cases an 5-fold reduction in the expression of lacZ reporter
driven by cap-dependent initiation was observed. Since eIF2A
was also found to genetically interact with GIM3, GIM5, and
PAC10 genes (members of the prefoldin complex) (37), we also
tested whether mutations in these genes could affect the activ-
ity of the URE2 IRES. No apparent change in URE2 IRES
activity was observed when comparing isogenic GIM3, GIM5,
and PAC10 null mutants and the WT BY4741 strain (Table I,
Fig. 3C). It was concluded that up-regulation of URE2 IRES in
eIF2A null strain could primarily be related to the activity of
eIF2A protein.
Expression of eIF2A Down-regulates URE2 IRES Activity in
Yeast Cells—To further address the possibility that eIF2A
functions as a suppressor of Ure2p IRES-mediated translation
initiation, the yeast eIF2A gene was reintroduced into the
eIF2A knockout yeast strain expressing the Ure2p-lacZ fusion
construct. eIF2A was expressed either from its own promoter in
a YCplac111 plasmid (Fig. 4A) or as an HA-tagged eIF2A
expressed from the GAL promoter in the pTB328 plasmid. In
both cases, down-regulation of URE2 IRES activity was ob-
served (Fig. 4A); however, overexpression of eIF2A from the
GAL promoter down-regulated URE2 IRES activity more effi-
ciently. The eIF2A knockout strain transformed with either the
pTB328 or YCplac111 plasmids was used as a control, and no
down-regulation of URE2 IRES activity was observed in the
latter cases. Also tested was whether human eIF2A (which is
28% identical and 58% similar to the yeast protein in amino
acid sequence) could substitute for its yeast homologue in vivo.
It was found that human HA-tagged eIF2A can also suppress
the expression from the URE2 IRES element, but it functions
about 60% as well as yeast HA-tagged eIF2A in repressing the
expression of lacZ (Fig. 4A). Both yeast and human proteins
were found to be associated with 40 and 80 S ribosomes; how-
ever, association of the human protein with 80 S ribosomes was
significantly reduced (Fig. 4B), and in contrast to the yeast
protein, the human homologue was found predominantly asso-
ciated with 40 S ribosomes. We anticipate that the reduced
association of human eIF2A with 80 S ribosomes could account
for its reduced ability to suppress expression from the URE2
IRES element (by comparison with the yeast protein).
It should be noted that no apparent change in URE2_lacZ
mRNA levels was observed when comparing WT yeast, yeast
eIF2A knockout, and yeast eIF2A knockout strains trans-
formed with either yeast or human eIF2A that could account
for the observed difference in lacZ activity (Fig. 4C). Thus, it
was concluded that eIF2A functions as a negative regulator of
Ure2p IRES-mediated expression. Interestingly, only a 2-fold
reduction ofURE2 IRES activity was observed in theWT strain
when overexpressing HA-tagged yeast eIF2A. This could indi-
cate that under the experimental conditions used, eIF2A is
present in wild-type yeast cells at sufficiently high concentra-
tions such that an increase in eIF2A levels does not further
reduce expression from the Ure2p IRES element.
Association of eIF2A with 40 and 80 S Is Not Impaired in the
FUN12 (eIF5B) Strain—We have previously shown the ge-
netic interaction between eIF2A and eIF5B (14). eIF5B was
also known to interact with eIF2A in the process of 80 S
complex formation in a reconstituted system when using AUG
codon (7). We decided to check whether the presence of eIF5B
affected the binding of eIF2A to either 40 or 80 S ribosome in
vivo in yeast cells. The HA-tagged eIF2A was transformed into
an isogenic WT strain BY4741 (MATa, his3-1, leu2-0, met15-0,
ura3-0) and eIF5B (MATa, his3-1, leu2-0, met15-0, ura3-0,
fun12::KanMX), and we found that similar amounts of HA-
tagged eIF2A were present in the 40 and 80 S ribosomes of the
WT and eIF5B strains (Fig. 5A). It was concluded that the
absence of eIF5B does not affect binding of eIF2A to 40 and 80
S ribosomes. If, as we hypothesized, suppression of IRES ac-
tivity through eIF2A protein in yeast cells occurs at the level of
40 S/80 S ribosomes, one would then expect that there will be
no change in URE2 IRES activity in eIF5B cells. Indeed, as
expected, we observed no difference in lacZ expression driven
by URE2 IRES in eIF5B cells in comparison with WT yeast
cells (Fig. 3A).
eIF2A Remains Bound to 40 and 80 S Subunits in Extracts of
prt1-1 Cells Incubated at the Nonpermissive Temperature—The
prt1-1 mutation replaces Ser518 with Phe in the Prt1p (eIF3b)
subunit of yeast eIF3 and confers a ts phenotype. Incubation of
prt1-1 cells at the nonpermissive (37 °C) temperature produces
a run-off of polysomes and accumulation of 80 S monosomes
(38). We asked whether incubating prt1-1 cells at the nonper-
missive temperature would change the amount of eIF2A asso-
ciated with 40 S/80 S subunits. We found that eIF2A remained
bound to 40 and 80 S subunits in the prt1-1 cells at the non-
permissive temperature and that the amount of eIF2A bound to
80 S ribosomes increased slightly with the accumulation of 80
monosomes at the nonpermissive temperature (Fig. 5B, right).
eIF2A Is an Inherently Unstable Protein—From the Stanford
yeast genome expression connection data base (available on the
World Wide Web at genome-www.stanford.edu/yeast_stress/),
it is known that the mRNA levels for eIF2A are highest under
optimal growth conditions and decrease 2–8-fold under a wide
variety of stress conditions, including heat shock, nitrogen
depletion, amino acid starvation, diauxic shift, and stationary
phase among others. We hypothesize that the decrease in
eIF2A mRNA levels would be accompanied by a decrease in
TABLE I
Strains of S. cerevisiae used in this study
Strain Genotype Source
CWO4 MATa, ade2-1, leu2-3,112, his3-11,15, trp1-1, ura3 P. Linder
4-2 MATa, ade2-1, leu2-3,112, his3-11,15, trp1-1, ura3, cdc33::LEU2 cdc33-4-2; TRP1, ARSCEN M. Altmann
4-2/2A MATa, ade2–1, leu2-3,112, his3-11,15, trp1-1, ura3, ygr054w::KanMX, cdc33::LEU2
cdc33-4-2; TRP1, ARSCEN This work
BY4741 MATa, his3-1, leu2-0, met15-0, ura3-0 Research Genetics
BY4741 (eIF2A) MATa, his3-1, leu2-0, met15-0, ura3-0, ygr054w::KanMX Research Genetics
BY4741 (eIF5B) MATa, his3-1, leu2-0, met15-0, ura3-0, fun12::KanMX Research Genetics
BY4741 (GIM3) MATa, his3-1, leu2-0, met15-0, ura3-0, gim3::KanMX T. Dever
BY4741 (GIM5) MATa, his3-1, leu2-0, met15-0, ura3-0, gim5::KanMX T. Dever
BY4741 (PAC10) MATa, his3-1, leu2-0, met15-0, ura3-0, pac10::KanMX T. Dever
H2879 MATa, leu2-3, leu2-112, ura3-52, PRT1 T. Dever
H1676 MATa, leu2-3, leu2-112, ura3-52, prt1-1 T. Dever
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eIF2A protein levels. To address this question, we monitored
the levels of HA-tagged eIF2A (which is under the control of the
GAL promoter) by immunoblotting with anti-HA antibodies
and compared them with the level of HA-tagged eIF4E (placed
also under the control of the GAL promoter). A similar ap-
proach was used to address the question of cyclin 2 stability in
yeast cells and was proven to be appropriate (39). Both HA-
tagged eIF2A and HA-tagged eIF4E constructs were trans-
formed into the eIF2A strain, and the levels of HA-tagged
proteins were monitored in the presence of galactose and then
subsequently following transfer to glucose. Repression, acting
through the upstream repression sequence element in the GAL
promoter, is established rapidly, within a few min of glucose
addition, leading to an immediate cessation of the galactose-
dependent mRNA synthesis (40). Thus, it was possible to de-
termine the half-life of HA-tagged eIF2A under the conditions
where there was no continued synthesis of eIF2A protein. By
Western blotting with an HA antibody, it was found that the
levels of HA-tagged eIF2A and eIF4E are about the same when
cells are grown on galactose (Fig. 6, A, C, and D). Upon transfer
to glucose, the levels of HA-tagged eIF4E remained unchanged
for about 1.5–2 h, whereas the levels of HA-tagged eIF2A were
rapidly reduced with an estimated half-life of 17–18 min. The
lack of a drop in signal in the case of the HA-tagged eIF4E
reflects, in part, a lag in the growth curve for the yeast in their
adaptation to growth on glucose (i.e. there is no apparent
change in A600 until roughly 2 h following the switch to glucose
(Fig. 6B)). With more extended periods of time, there is the
expected decrease in HA-tagged eIF4E concomitant with the
increase in cell number (i.e. a dilution effect; data not shown).
In contrast to HA-tagged eIF4E, a rapid drop-off in the signal
for HA-tagged eIF2A was observed, suggesting that HA-tagged
eIF2A is an inherently unstable protein. We used an HA
epitope tag for detection, since the monoclonal antibodies
against HA epitope are extremely sensitive, allowing one to
detect very low levels of the tagged protein. One caveat to this
experiment is that the observed instability of HA-tagged eIF2A
could be apparent and might result from the rapid cleavage of
the HA epitope. To verify our conclusion, we also used a poly-
clonal antibody derived against the central core fragment
(Gly59–Glu420) of the recombinant eIF2A and measured the
half-life of the HA-tagged eIF2A after repression of the GAL1
promoter by glucose. A similar decay of the eIF2A signal was
observed (Fig. 6F).
Interestingly, a strong proline, glutamic acid, serine, threo-
nine (PEST) motif (41, 42) of 24 amino acids (KSSETSPDST-
FIG. 4. eIF2A acts as a suppressor of
the Ure2p IRES element in yeast
cells. A, cells expressing the Ure2-lacZ
reporter constructs under the control of
the GAL1/10 promoter were co-trans-
formed with vectors expressing either
HA-tagged yeast eIF2A or HA-tagged hu-
man eIF2A from their respective GAL
promoters. A vector lacking the eIF2A
gene was used as a control. -Galactosid-
ase activity (relative units) was deter-
mined after a 20-h induction. B, Western
blot analysis of eIF2A strain trans-
formed with an HA-tagged eIF2A clones.
Extracts from eIF2A yeast strains carry-
ing plasmids encoding either yeast or hu-
man HA-tagged eIF2A were subjected to
sucrose gradient (10–50%) centrifuga-
tion. Fractions from the gradients were
collected and resolved by SDS-PAGE.
Subsequently, proteins were transferred
to Immobilon membranes and probed
with antibodies to the HA epitope. C,
Northern blot analysis of Ure2p-lacZ
mRNA expressed in WT strain, eIF2A
strain, eIF2A strain transformed with
yeast HA-tagged eIF2A, or eIF2A strain
transformed with human HA-tagged
eIF2A. For each lane, 25 g of total yeast
RNA was separated on a denaturing aga-
rose gel, transferred onto a BrightStarTM-
Plus Nylon membrane (Ambion), and hy-
bridized to a 32P-labeled DNA lacZ probe.
rRNA loading control is shown below the
Northern blot.
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PAPSAPASTNAPTNNK) exists between positions 559 and 584
of the eIF2A amino acid sequence with a PEST score of 16.12
calculated using the PEST-FIND program (available on the
World Wide Web at www.hgmp.mrc.ac.uk/Software/EMBOSS/
Apps/pestfind.html) originally developed by Scott Rogers and
Martin Rechsteiner in 1986. It is widely believed that PEST
sequences are responsible for rapid degradation of proteins
containing this motif, and a PEST score of more than 5 denotes
a very strong proteolytic degradation signal (41, 42). eIF2A is
also found to be among 1075 proteins identified as yeast ubiq-
uitin conjugates (43). Ubiquitinated proteins are well known to
be substrates for rapid turnover (44). This was not the case for
eIF4E or any of the three subunits of initiation factor eIF2 (43).
It should be noted that no significant difference in the levels of
the two mRNAs was observed as determined by Northern blot-
ting, and both mRNAs were almost completely degraded after
20 min following the switch from galactose to glucose (Fig. 4E).
DISCUSSION
Genetic analyses have proven to be a powerful tool for elu-
cidating the biological function of proteins in S. cerevisiae, and
eIF2A has now appeared in several genetic screens (14, 37).
First, it was shown to genetically interact with eIF5B (14). This
suggests that both proteins function in the same pathway (14).
Although our experiments with FUN12 strain did not support
the idea of a direct physical interaction of these two proteins in
vivo during binding to 40 S/80 S ribosomes, they did not exclude
the possibility that this interaction could be through some
other protein or the ribosome either. Indeed, genetically inter-
acting genes do encode proteins often found in the same com-
plex, however, global analyses have shown that only 30 of 4039
genetically interacting gene pairs in S. cerevisiae encode phys-
ically interacting proteins (37). Very recently, eIF2A was also
found to genetically interact with the members of the prefoldin
complex, GIM3, GIM5, and PAC10 (37). The double knockouts
of eIF2A/GIM3, eIF2A/GIM5, and eIF2A/PAC10 mutants dis-
play a severe slow growth phenotype (37). Members of the GIM
family in yeast are important for the folding of tubulin and
actin (45). Prefoldin binds ribosome-associated actin chains
after synthesis of the first 145 amino acids and remains
bound to the actin polypeptide until its posttranslational deliv-
ery to the cytosolic chaperonin (46). Members of the prefoldin
complex in contrast to eIF2A are predominantly associated
with polysomes and not with 40 S/80 S ribosomes (46). The
rapid assembly and disassembly of actin and tubulin filaments
at specific subcellular locations provides the mechanistic basis
for various dynamic activities such as segregation of chromo-
somes, change of cell shape/morphology, translocation of intra-
cellular organelles, and others (47). Although none of the above
mentioned genes have an obvious direct relationship with the
translation process, this observation provides additional evi-
dence that eIF2A might have a critical function in yeast in
controlling (under certain specific conditions) the expression of
the genes involved in cytoskeleton formation and assembly,
and this could finally lead to a change of cell morphology. Our
findings that the eIF4E-ts/eIF2A yeast strain displays al-
tered actin organization when compared with the parental
strains as well as an affected morphogenic processes supports
this suggestion. The significant increase in actin levels ob-
served in the eIF4E-ts/eIF2A strain may be the cause of a
slow growth phenotype. Remarkably, overexpression of actin is
lethal in yeast; however, the reason for this sensitivity is not
well understood (48, 49). It is unclear which gene expression is
affected in the 4-2/2A strain that subsequently causes the
observed changes in cell shape, actin disorganization, and actin
levels. However, the genetic interaction of eIF4E and eIF2A
reported here clearly shows that both proteins function in the
same pathway.
It should be noted that translational control of gene expres-
sion has become the focus of many studies during the last 10
years. Recent studies have led to an increase in our under-
standing of how the balance between different initiation mech-
anisms (namely cap-dependent initiation, leaky scanning,
reinitiation, and internal initiation) might influence cell fate
(3–5, 50). This can be accomplished through the mechanisms
that target specific initiation factors (altering their activity,
affecting their integrity or protein levels). So far, initiation
factors eIF4E, eIF4G, eIF2, and eIF2B have proven to be the
main targets for translational control (51–55). In general, their
inactivation is triggered by stress and their activation by
growth proliferation signals. A part of the overall effect of
stress is the decrease in cap-dependent translation through a
reduction of eIF4F activity. At the same time, however, many
mRNAs continue to be translated or become more efficiently
translated under these conditions (56). These mRNAs are the
most competitive, cap-dependently translated mRNAs or those
mRNAs that are internally initiated (IRES containing).
In the past few years, IRES elements have been detected in
an increasing number of cellular mRNAs from various species
FIG. 5.Ribosome profile and Western blot analysis of the yeast
strains transformed with an HA-tagged eIF2A clone. A, extracts
from WT BY4741 (left) and isogenic eIF5B (right) yeast strains carry-
ing a plasmid encoding the wild type HA-eIF2A under control of a
galactose inducible promoter were subjected to sucrose gradient (10–
25%) centrifugation. B, extracts from isogenic PRT1 (H2879) and prt1-1
(H1676) cells (carrying the same plasmid encoding the wild type HA-
eIF2A under control of a galactose-inducible promoter) grown in YPD
medium at 28 °C and treated for 15 min at 37 °C were subjected to
sucrose gradient (10–25%) centrifugation. Each fraction from the gra-
dient was precipitated with cold 10% trichloroacetic acid, resuspended
in SDS sample buffer, and subjected to electrophoresis. Subsequently,
proteins were transferred to Immobilon membranes and probed with
the monoclonal antibodies to the HA epitope.
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(57, 58). Remarkably most of these IRES elements initiate
translation of proteins that protect cells from stress or at least
help them to cope with transient stress conditions (57, 58). The
exact molecular mechanisms that redirect the ribosome from
the m7G cap structure to the IRES elements under such con-
ditions are unknown. One simple possibility is that the inhibi-
tion of cap-dependent translation through sequestration of
eIF4E by the eIF4E binding protein frees other initiation fac-
FIG. 6. Yeast eIF2A is unstable protein. A, eIF2A yeast cells co-transformed with HA-tagged eIF2A and HA-tagged eIF4E expression
plasmids were grown overnight (18 h) on galactose YP-rich medium to allow for the expression of both HA-tagged eIF2A and HA-tagged eIF4E from
their respective GAL promoters. Yeast cells co-transformed with ancestor plasmids that do not contain either eIF2A or eIF4E genes were used as
control (lane C). At time 0, the cells were washed with water and then resuspended in YP medium containing glucose. Aliquots (50 ml) of the cells
were taken at the indicated times. The yeast were pelleted and then dissolved in 200 l of 20 mM HEPES/KOH buffer (pH 7.4) containing 100 mM
KCl, 2 mM MgAc, 14.4 mM -mercaptoethanol, 100 g/ml cycloheximide. The cells were lysed by subsequent cycles of freezing in liquid nitrogen
and thawing at 37 °C, and insoluble material was pelleted by centrifugation. Approximately equal amounts of protein from the supernatants were
subjected to SDS Tris/Tricine 11.5% acrylamide gel electrophoresis. Proteins were transferred to nitrocellulose membranes and probed with
anti-HA antibodies (Santa Cruz Biotechnology). B, yeast cell growth (A600) following the shift from galactose to glucose. C, the relative ratio of
HA-tagged eIF4E and HA-tagged eIF2A as determined densitometrically from A. D, time course of HA-tagged eIF4E and HA-tagged eIF2A
degradation in eIF2A yeast cells. The quantitative data from C are plotted as log (relative intensity) versus time in order to estimate the protein
half-life of HA-tagged eIF4E and HA-tagged eIF2A. Under the experimental conditions, no loss of HA-tagged eIF4E was observed, whereas
HA-tagged eIF2A disappeared with a half-life of 17–18 min. E, Northern blot analysis of mRNA for HA-tagged eIF2A and HA-tagged eIF4E
expressed in the eIF2A strain. Total RNA was isolated from eIF2A yeast strain harboring plasmids expressing HA-tagged eIF2A and HA-tagged
eIF4E at 0, 10, 20, and 30 min following the switch from galactose to glucose. For each lane, 15 g of total yeast RNA was separated on a denaturing
agarose gel, transferred onto BrightStart-Plus nylon membrane (Ambion), and hybridized to a 32P-labeled DNA HA probes. The half-life of both
mRNAs was less than 10 min. F, Western blot analysis of the eIF2A strain transformed with an HA-tagged eIF2A clones. Custommade antibodies
derived against a central core fragment (Gly59–Glu420) of recombinant eIF2A were used. Samples were prepared as in A. Protein loading control
is shown to the right of the Western blot.
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tors for the IRES-mediated processes. Few of the IRES contain-
ing mRNAs require the cap-binding factor eIF4E or intact
eIF4G (i.e. missing the eIF4E-binding domain in the N termi-
nus) for their translation (57) and, under conditions of reduced
global translation, mRNAs containing IRES elements gener-
ally become more competitive for ribosome binding.
We have also shown here that eIF2A functions as a suppres-
sor of IRES-mediated translation in yeast S. cerevisiae at least
as tested using the Ure2p IRES reporter system. The mecha-
nistic basis for this increased induction of Ure2p IRES expres-
sion in eIF2A cells over what is seen in the WT yeast is
unclear. Two possibilities exist. First, eIF2A might act directly
by slowing the rate of IRES-containing mRNA binding to 40 S
subunits or by slowing the steps between the 48 S complex and
the elongating 80 S ribosome. In this regard, the finding of
eIF2A bound to 40 and 80 S ribosomes would support this
suggestion (14). Second, eIF2A might function indirectly by
affecting the synthesis of some protein that directly influences
IRES-mediated expression. Given that mammalian eIF2A was
previously shown to not stimulate expression from globin
mRNA (7), it is possible that eIF2A specifically binds and
affects the translation of only a subset of mRNAs such as
IRES-containing mRNAs. If one assumes a mechanism for
eIF2A function based upon its similarity in biochemical prop-
erties to those of IF2 (binding of an aminoacyl-tRNA to ribo-
somes in a codon-dependent manner), it would appear likely
that eIF2A actively participates in the initiation process. The
finding of eIF2A in 48 and 80 S complexes (Fig. 4 and data in
Ref. 14), and the fact that it marginally affects cap-dependent
initiation supports this suggestion. We hypothesize that the
release of eIF2A from 48 and 80 S complexes is much slower
than the release of eIF2, and thus, although eIF2A is function-
ing in a positive, synthetic direction, the fact that it is acting so
much more slowly than eIF2 results in “apparent suppression,”
causing a delay in the transition of the 80 S ribosome to the
elongation cycle. This suggestion is supported by an earlier
observation on AUG-directed methionyl-puromycin synthesis
using salt-washed ribosomes and purified rabbit eIF2 and
eIF2A (7).
Consistent with this hypothesis is the observation in yeast
that human eIF2A can only partially suppress Ure2p IRES
activity and was found to be less abundant in the 80 S ribo-
somes (Fig. 4B). At the same time, no change in URE2 IRES
activity was observed in eIF5B cells, and the binding of the
yeast eIF2A to 40 and 80 S ribosomes was not impaired either.
The accumulation of eIF2A in 80 S complexes in prt1-1 cells at
the nonpermissive temperature also supports the suggestion
that eIF2Amight act during the transition of the 80 S initiation
complex to the elongatiing 80 S ribosome (eIF2A is assumed to
be released during this transition, since it is not found in
polysomes (14)).
Taking together the genetic and biochemical data and as-
suming the nature of eIF2A being a translation initiation fac-
tor, one might suggest that eIF2A is involved in a process that
impinges on the expression of many specific proteins. The ex-
pression of these proteins in yeast can be controlled by IRES
elements. Since the deletion of eIF2A in the eIF4E-ts back-
ground results in slow growth and altered phenotype, we an-
ticipate that several IRES-containing mRNAs are up-regulated
and either directly or indirectly lead to the aberrant pheno-
types we have observed. Although only proven for the Ure2p
IRES element, we hypothesize that eIF2A might act as a global
suppressor of IRES-mediated expression allowing for transla-
tional control through the levels of eIF2A protein, since eIF2A
was found to be an inherently unstable protein. Future exper-
iments are required to determine if this is indeed the case.
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